new_0222_0670|CNTA|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
new_0222_0670|CNTA|Long Name|1|1|Centessa Pharmaceuticals PLC Total Current Assets (Quarterly) (USD)|Centessa Pharmaceuticals PLC Cash and Short Term Investments (Quarterly) (USD)|Centessa Pharmaceuticals PLC Inventories (Quarterly) (USD)|Centessa Pharmaceuticals PLC Net PP&E (Quarterly) (USD)|Centessa Pharmaceuticals PLC Goodwill and Intangibles (Quarterly) (USD)|Centessa Pharmaceuticals PLC Total Liabilities (Quarterly) (USD)|Centessa Pharmaceuticals PLC Total Current Liabilities (Quarterly) (USD)|Centessa Pharmaceuticals PLC Total Long Term Liabilities (Quarterly) (USD)|Centessa Pharmaceuticals PLC Total Deposits (Quarterly) (USD)|Centessa Pharmaceuticals PLC Book Value (Quarterly) (USD)|Centessa Pharmaceuticals PLC Retained Earnings (Quarterly) (USD)|Centessa Pharmaceuticals PLC Treasury Stock (Quarterly) (USD)|Centessa Pharmaceuticals PLC EV to Revenues|Centessa Pharmaceuticals PLC EV to Earnings|Centessa Pharmaceuticals PLC EV to Free Cash Flow|Centessa Pharmaceuticals PLC EV to Assets (Quarterly)|Centessa Pharmaceuticals PLC PS Ratio|Centessa Pharmaceuticals PLC PE Ratio|Centessa Pharmaceuticals PLC Price to Book Value|Centessa Pharmaceuticals PLC PEG Ratio|Centessa Pharmaceuticals PLC Debt to Equity Ratio|Centessa Pharmaceuticals PLC Dividend Yield|Centessa Pharmaceuticals PLC Shareholder Yield (TTM)|Centessa Pharmaceuticals PLC Percent of Shares Outstanding Short|Centessa Pharmaceuticals PLC Total Receivables (Quarterly) (USD)|Centessa Pharmaceuticals PLC Total Payables (Quarterly) (USD)|Centessa Pharmaceuticals PLC Total Capital Stock (Quarterly) (USD)|Centessa Pharmaceuticals PLC Return on Invested Capital|Centessa Pharmaceuticals PLC Quality Ratio Score|Centessa Pharmaceuticals PLC Momentum Score|Centessa Pharmaceuticals PLC Beta (1Y)|Centessa Pharmaceuticals PLC Sustainable Growth Rate (TTM)|Centessa Pharmaceuticals PLC Institutional Investor Ownership Percentage|Centessa Pharmaceuticals PLC Average Diluted Shares Outstanding (Quarterly)|Centessa Pharmaceuticals PLC Total Employees (Annual)|Centessa Pharmaceuticals PLC EPS Diluted (Quarterly) (USD)|Centessa Pharmaceuticals PLC Shares Outstanding|Centessa Pharmaceuticals PLC Repurchase of Capital Stock (Quarterly) (USD)|Centessa Pharmaceuticals PLC Ordinary Shares Number (Quarterly)|Centessa Pharmaceuticals PLC Payout Ratio|Centessa Pharmaceuticals PLC Quick Ratio (Quarterly)|Centessa Pharmaceuticals PLC Normalized Diluted EPS (Quarterly) (USD)|Centessa Pharmaceuticals PLC Stock Buybacks (Quarterly) (USD)|Centessa Pharmaceuticals PLC Effective Tax Rate (TTM)|Centessa Pharmaceuticals PLC Return on Equity|Centessa Pharmaceuticals PLC Net Income (TTM) (USD)|Centessa Pharmaceuticals PLC Revenue (TTM) (USD)|Centessa Pharmaceuticals PLC Dividend Per Share (Quarterly) (USD)|Centessa Pharmaceuticals PLC Revenue (Quarterly) (USD)|Centessa Pharmaceuticals PLC Gross Profit (Quarterly) (USD)|Centessa Pharmaceuticals PLC SG&A Expense (Quarterly) (USD)|Centessa Pharmaceuticals PLC Pre-Tax Income (Quarterly) (USD)|Centessa Pharmaceuticals PLC Net Income (Quarterly) (USD)|Centessa Pharmaceuticals PLC Net Interest Income (Quarterly) (USD)|Centessa Pharmaceuticals PLC Price (USD)|Centessa Pharmaceuticals PLC Total Return Price (USD)|Centessa Pharmaceuticals PLC Enterprise Value (USD)|Centessa Pharmaceuticals PLC 30-Day Average Daily Volume|Centessa Pharmaceuticals PLC 1 Year Price Returns (Daily)
new_0222_0670|CNTA|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
new_0222_0670|CNTA||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly
new_0222_0670|CNTA||5|5|91.5|91.5|0|91.5|0|91.5|91.5|91.5|0|91.5|91.5|0|0|0|0|0|0|0|1.44565217391|0|0|1.44808743169|0|15.5|91.5|91.5|91.5|0|0|0|0|0|30.625|92|0|92|21.875|0|91.5|0|0|92|0|0|0|0|0|0|0|0|92|92|92|92|1.44565217391|1.44565217391|1.44808743169|1.42857142857|0
new_0222_0670|CNTA||6|6|2|2|0|2|0|2|2|2|0|2|2|0|0|0|0|0|0|0|184|0|0|183|0|16|2|2|2|0|0|0|0|0|8|1|0|1|8|0|2|0|0|1|0|0|0|0|0|0|0|0|1|1|1|1|184|184|183|154|0
new_0222_0670|CNTA||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
new_0222_0670|CNTA|202103|202103|202103|313.636|298.612||0.045||41.886|18.977|22.909||30.787|-243.273||||||||||||||12.954|12.216|247.98||||||||||||85.9244||||||||||||||||||||
new_0222_0670|CNTA|202105|202103|202103|||||||||||||||||||61.7625|||0||0|||||||||0.9364||||87.4244||||||||||||||||||21.75|21.75|1851.0067||
new_0222_0670|CNTA|202106|202106|202106|643.682|613.759||0.075||58.115|24.185|33.93||585.642|-284.724||||||||3.4094|||0||0.9031|15.304|7.261|0.252||||||62.649|63.5167||-0.65|89.8994||89.8994|||-0.4719|||||||||11.841|-41.451|-41.451|0.027|22.21|22.21|1382.9067||
new_0222_0670|CNTA|202107|202106|202106|||||||||||||||||||3.1684|||0||0.8298|||||||||62.3475||||||||||||||||||||||20.64|20.64|1241.7646|208929.0667|
new_0222_0670|CNTA|202108|202106|202106|||||||||||||||||||3.3848|||0||0.8713|||||||||62.1933||||89.8994||||||||||||||||||22.05|22.05|1368.5228|124098.1|
new_0222_0670|CNTA|202109|202109|202109|611.645|578.815||0.114||63.074|29.144|33.93||549.133|-324.879||||||||2.734|||0||1.3086|21.556|18.456|0.252||||||72.552|89.8995||-0.45|89.9004|-0.012|89.9004|||-0.45|-344.124||||||||12.464|-40.155|-40.155|0.065|16.7|16.7|922.5217|116191.8667|
new_0222_0670|CNTA|202110|202109|202109|||||||||||||||||||2.8159|||0||1.7338|||||||||71.7653||||||||||||||||||||||17.2|17.2|967.4719|220119.4667|
new_0222_0670|CNTA|202111|202109|202109|||||||||||||||||||1.94|||0||2.3357|||||||||71.6734||||89.9009||||||||||||||||||11.85|11.85|486.5107|198133.2333|
new_0222_0670|CNTA|202112|202112|202112|||||||||||||||||||1.8434|||0||2.457|||||||||71.7064||||||||||||||||||||||11.26|11.26|433.4691|191380.4333|
new_0222_0670|CNTA|202201|202112|202112|||||||||||||||||||1.5602|||0||3.5791|||||||||71.5331||||||||||||||||||||||9.53|9.53|277.9406|200803.5|
new_0222_0670|CNTA|202202|202112|202112|||||||||||||||||||1.4841|||0|||||||||||||||||||||||||||||||||9.065|9.065|282.4356|190698.3|